Procured an 8 hundred million yen social loan to be applied to repayment of existing borrowings. Interest rate is reference rate +0.25%; repayment will be made in a lump sum on 2026-12-01; unsecured and no guarantee. The financing obtained a Social 1 (F) evaluation under the SDGs Social Finance Framework.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3455","jir_company_name":"Healthcare & Medical Investment Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/3455-20260928-01.pdf","jir_short_summary":"Procured an 8 hundred million yen social loan to be applied to repayment of existing borrowings. Interest rate is reference rate +0.25%; repayment will be made in a lump sum on 2026-12-01; unsecured and no guarantee. The financing obtained a Social 1 (F) evaluation under the SDGs Social Finance Framework.","jir_summary":"### Overview of Financing\nHealthcare & Medical Investment Corporation procured 8 hundred million yen as a social loan to be applied to repayment of existing borrowings. The lender is Sumitomo Mitsui Banking Corporation, and the interest rate is set at the reference rate (Zengin Association 1-month JPY TIBOR) plus 0.25%. The loan will be executed on 2026-10-01 and is scheduled to be repaid in a lump sum by 2026-12-01. It is unsecured and without guarantee, and repayment is subject to fulfillment of lending preconditions to be separately specified.\n\n### Capital Policy Background and Risks\nThis borrowing has obtained a Social 1 (F) evaluation from JCR under the SDGs Social Finance Framework, and the funds are procured under a framework with high transparency and governance. Information on repayment risk follows the descriptions of investment risks in the securities registration statement submitted on 2026-08-19.","jir_financial_highlights":"Loan Amount: 8 hundred million yen (Unknown)\nInterest Rate: Reference rate (Zengin Association 1-month JPY TIBOR) +0.25% (Unknown)\nLoan Execution Date: 2026-10-01 (Unknown)\nRepayment Date: 2026-12-01 (Unknown)\nCollateral\/Guarantee: Unsecured No guarantee (Unknown)","jir_category":"","jir_hashtags":"#HealthcareAndMedicalInvestmentCorporation, #SocialFinance, #Fundraising","jir_key_figures":"Loan Amount: 8 hundred million yen\nLoan Execution Date: 2026-10-01\nRepayment Date: 2026-12-01","jir_meta_title":"Healthcare & Medical Investment Corporation: Procures 8 hundred million yen Social Loan for Repayment of Existing Borrowings","jir_meta_description":"Healthcare & Medical Investment Corporation procured an 8 hundred million yen social loan to be applied to repayment of existing borrowings. Interest rate is reference rate +0.25%, repayment in lump sum on 2026-12-01, unsecured and no guarantee. Obtained JCR Social 1 (F) evaluation.","jir_og_title":"Healthcare & Medical Investment Corporation Announces Social Loan Procurement","jir_og_description":"Procured an 8 hundred million yen social loan. Repayment in lump sum on 2026-12-01. Obtained JCR Social 1 (F) evaluation.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17572,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-123661","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n